The number of motorists who drive under the influence of drugs is difficult to calculate. The influence of a prescription drug can have a positive or a negative impact on driver fitness. This may be caused either by the intended therapeutic effect or the undesired side-effects. Before each trip, the patient must therefore check whether, having taken a drug, he or she is still fit to drive. From a traffic-medicine standpoint, the directions for use of the drug, especially the warning referring to driving a vehicle or operating machinery, may play an important role in explaining to the patient the potentially impairing effect a drug may have on driving fitness. In the research represented here, this warning is denoted as a "traffic warning." This paper aims to describe the extent to which statutory regulations regarding medication traffic warnings exist at both the national (Germany) and European level.

  • Availability:
  • Corporate Authors:

    PTRC Education and Research Services Limited

    Glenthorne House, Hammersmith Grove
    London W6OL9,   England 
  • Authors:
    • BECKER, S
    • FRIEDEL, B
  • Conference:
  • Publication Date: 2000


  • English

Media Info

Subject/Index Terms

Filing Info

  • Accession Number: 00797572
  • Record Type: Publication
  • Report/Paper Numbers: VTI konferens 13A, Part 2
  • Files: TRIS
  • Created Date: Aug 2 2000 12:00AM